- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Feb 22, 2025
Discovery & Translation
Science Spotlight: Bacterial payload delivery from nose to brain
BioCentury’s roundup of translational innovations also includes targeting MSH3 to slow repeat expansion in Huntington’s; plus AAVs for kidney and T cells
BioCentury | Oct 3, 2024
Finance
Kurma investing new fund; Kailera advancing obesity assets with $400M
BioCentury’s latest Venture Report also features news about LoQus23, Aktis, Resolution, Triveni, Flagship and more
BioCentury | Apr 27, 2021
Targets & Mechanisms
Triplet brings a new strategy to Huntington’s disease
Unveils preclinical POC data for its first DNA damage repair target
BioCentury | Aug 30, 2019
Translation in Brief
DNA trumps protein in Huntington onset
Mutant HTT DNA, not protein, could hold key to predicting and preventing Huntington disease onset
Items per page:
1 - 4 of 4